z-logo
open-access-imgOpen Access
A regulatory T cell Notch4–GDF15 axis licenses tissue inflammation in asthma
Author(s) -
Hani Harb,
Emmanuel Stephen-Victor,
Elena Crestani,
Mehdi Benamar,
Amir Hossein Massoud,
Ye Cui,
Louis-Marie Charbonnier,
Sena Arbag,
Safa Barış,
Amparito Cunnigham,
Juan Manuel Leyva-Castillo,
Amirhosein Mousavi,
Boris Guennewig,
Klaus SchmitzAbe,
Constantinos Sioutas,
Wanda Phipatanakul,
Talal Chatila
Publication year - 2020
Publication title -
nature immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 9.074
H-Index - 388
eISSN - 1529-2916
pISSN - 1529-2908
DOI - 10.1038/s41590-020-0777-3
Subject(s) - inflammation , immunology , wnt signaling pathway , innate lymphoid cell , biology , downregulation and upregulation , microbiology and biotechnology , allergic inflammation , interleukin 23 , immune system , innate immune system , cancer research , signal transduction , interleukin 17 , biochemistry , gene
Elucidating the mechanisms that sustain asthmatic inflammation is critical for precision therapies. We found that interleukin-6- and STAT3 transcription factor-dependent upregulation of Notch4 receptor on lung tissue regulatory T (T reg ) cells is necessary for allergens and particulate matter pollutants to promote airway inflammation. Notch4 subverted T reg cells into the type 2 and type 17 helper (T H 2 and T H 17) effector T cells by Wnt and Hippo pathway-dependent mechanisms. Wnt activation induced growth and differentiation factor 15 expression in T reg cells, which activated group 2 innate lymphoid cells to provide a feed-forward mechanism for aggravated inflammation. Notch4, Wnt and Hippo were upregulated in circulating T reg cells of individuals with asthma as a function of disease severity, in association with reduced T reg cell-mediated suppression. Our studies thus identify Notch4-mediated immune tolerance subversion as a fundamental mechanism that licenses tissue inflammation in asthma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here